explore -WSS

explore

author：focus 2025-09-28 23:30:20 - browse：69

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Medicare Advantage enrollment hits roughly 33.4 million

hotspot

WSS

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

New air purifier tech could be key to improving indoor air quality

Wildfire smoke exposes gaps in outdoor worker protections

Novavax promises a turnaround & Lilly roils the obesity market

Activists slam private health insurers over coverage restrictions

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

leisure time

explore

knowledge

Walensky prepares to leave CDC — and Congress — behind

What does generative AI mean for health care? We asked experts

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Medical leaders decry Supreme Court decision on affirmative action

Tori Bowie and the unacceptable rates of Black maternal death

Moonlake's readout produced a cash windfall. Risks remain

WATCH: Why do our ears pop?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Wildfire smoke exposes gaps in outdoor worker protections

focus

FDA warns medical device makers about rise in fabricated data

Novavax promises a turnaround & Lilly roils the obesity market

New CMS data security rules will hurt Medicare, Medicaid research

DIEP, the 'gold standard' of breast reconstruction, is under threat

Peter Hotez and the public health issue of online harassment

WATCH: Why do our ears pop?

hotspot

leisure time

hotspot

Wikipedia